Silver Bullet Therapeutics is advancing the OrthoFuzIon™ Bone Screw System, which features an innovative antimicrobial coating that utilizes proprietary silver ionization technology. This technology is specifically designed to mitigate the risk of bacterial contamination associated with medical device implants, addressing a significant clinical need in the healthcare sector. By preventing infections that can arise from the implantation of medical devices, Silver Bullet aims to enhance patient safety and improve outcomes in surgical procedures.

The company recognizes the potential market opportunities for its OrthoFuzIon™ system, particularly in light of healthcare payment models such as the CMS “Bundled Payments for Care Improvement” (BPCI), which may incentivize the adoption of technologies that reduce infection rates and associated healthcare costs. While the OrthoFuzIon™ system and its underlying technology are not yet cleared for sale in the United States, Silver Bullet Therapeutics is focused on developing solutions that set a new standard for antimicrobial protection in medical devices.

United States

Silver Bullet Therapeutics is an early stage company dedicated to the treatment of osteomyelitis. Through the use of proprietary implants that can be placed using local anesthesia and minimal sedation, the duration of exposure to long-term intravenous antibiotic will be shortened.

2362 qume dr, san jose, california, united states, 95131-1812

Silver Bullet Therapeutics

California - North

Silver Bullet Therapeutics

Company Details